Penumbra Inc (PEN)
244.84
+4.35
(+1.81%)
USD |
NYSE |
Nov 22, 16:00
244.84
0.00 (0.00%)
After-Hours: 20:00
Penumbra Enterprise Value: 9.106B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 9.106B |
| November 21, 2024 | 8.939B |
| November 20, 2024 | 8.889B |
| November 19, 2024 | 8.809B |
| November 18, 2024 | 8.938B |
| November 15, 2024 | 8.837B |
| November 14, 2024 | 8.671B |
| November 13, 2024 | 8.768B |
| November 12, 2024 | 8.775B |
| November 11, 2024 | 8.999B |
| November 08, 2024 | 8.784B |
| November 07, 2024 | 8.654B |
| November 06, 2024 | 8.678B |
| November 05, 2024 | 8.628B |
| November 04, 2024 | 8.517B |
| November 01, 2024 | 8.663B |
| October 31, 2024 | 8.493B |
| October 30, 2024 | 7.818B |
| October 29, 2024 | 7.754B |
| October 28, 2024 | 7.720B |
| October 25, 2024 | 7.566B |
| October 24, 2024 | 7.636B |
| October 23, 2024 | 7.527B |
| October 22, 2024 | 7.601B |
| October 21, 2024 | 7.641B |
| Date | Value |
|---|---|
| October 18, 2024 | 7.717B |
| October 17, 2024 | 7.472B |
| October 16, 2024 | 7.593B |
| October 15, 2024 | 7.636B |
| October 14, 2024 | 7.817B |
| October 11, 2024 | 7.504B |
| October 10, 2024 | 7.097B |
| October 09, 2024 | 7.288B |
| October 08, 2024 | 7.183B |
| October 07, 2024 | 7.029B |
| October 04, 2024 | 7.179B |
| October 03, 2024 | 7.189B |
| October 02, 2024 | 7.114B |
| October 01, 2024 | 7.058B |
| September 30, 2024 | 7.163B |
| September 27, 2024 | 7.101B |
| September 26, 2024 | 7.104B |
| September 25, 2024 | 6.920B |
| September 24, 2024 | 7.095B |
| September 23, 2024 | 7.231B |
| September 20, 2024 | 7.235B |
| September 19, 2024 | 7.461B |
| September 18, 2024 | 7.257B |
| September 17, 2024 | 6.926B |
| September 16, 2024 | 6.949B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.134B
Minimum
Jun 16 2022
12.99B
Maximum
Jun 30 2023
8.109B
Average
8.124B
Median
Aug 06 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.27B |
| Repligen Corp | 7.726B |
| Inari Medical Inc | 2.796B |
| Bruker Corp | 10.84B |
| QuidelOrtho Corp | 5.106B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 29.53M |
| Revenue (Quarterly) | 301.04M |
| Total Expenses (Quarterly) | 265.68M |
| EPS Diluted (Quarterly) | 0.75 |
| Gross Profit Margin (Quarterly) | 66.54% |
| Profit Margin (Quarterly) | 9.81% |
| Earnings Yield | 0.35% |
| Operating Earnings Yield | 0.82% |
| Normalized Earnings Yield | 0.9775 |